An Exploratory Safety and Efficacy Clinical Study of CARDIX-101 for the Treatment of Chronic Bradycardia

NCT05117346 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Bradycardia

Interventions

DRUG: CARDIX-101A, CARDIX-101B, CARDIX-101C

Sponsor

Cardix Therapeutics LLC